Trade Summary

4 days ago, PERRY MICHAEL S, serving as Dir at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 11,600 shares at $87.30 per share, for a total transaction value of $1,012,680.00. Following this transaction, PERRY MICHAEL S now holds 111,459 shares of ARWR.

This sale represents a 9.43% decrease in PERRY MICHAEL S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, August 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 5:22 PM ET, 2 days after the trade was made.

ARROWHEAD PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.